(Q81324991)
Statements
Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia (English)
Eduardo Olavarria
Shamyla Siddique
Michael J Griffiths
Sharon Avery
Karen P Piper
Anne L Lennard
Lalit Pallan
Julie M Arrazi
Jolanta B Perz
Derville O'Shea
John M Goldman
19 September 2007